Myeloablative radioimmunotherapy with Re-188-anti- CD66-Antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation - Buchmann, I; Bunjes, D; Kotzerke, J (Cancer Biother & Radiopharm, 2002)